Skip to main content

Peer Review reports

From: The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections – a randomized, double-blinded, placebo-controlled clinical trial study protocol

Original Submission
6 Sep 2016 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
14 Nov 2016 Editorially accepted
1 Dec 2016 Article published 10.1186/s12879-016-2022-0

You can find further information about peer review here.

Back to article page